Grace Therapeutics, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
|
|
Average Rating
|
4.50
|
|
# Strong Buys
|
1
|
|
# Buys
|
1
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2024-09-30
|
0.00
|
-0.30
|
0.00
|
0.00%
|
|
2024-06-30
|
0.00
|
-0.24
|
0.00
|
0.00%
|
|
2024-03-31
|
0.00
|
-0.34
|
0.00
|
0.00%
|
|
2023-12-31
|
0.00
|
-0.21
|
0.00
|
0.00%
|
|
2023-09-30
|
0.00
|
-0.43
|
0.00
|
0.00%
|
|
2023-06-30
|
0.00
|
-0.54
|
0.00
|
0.00%
|
|
2023-03-31
|
0.00
|
-3.91
|
0.00
|
0.00%
|
|
2022-12-31
|
0.00
|
-0.52
|
0.00
|
0.00%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2024-09-30
|
-0.54
|
|
2024-03-31
|
-1.52
|
|
2023-03-31
|
-5.71
|
|
2022-03-31
|
-1.58
|
|
2021-03-31
|
-32.77
|
|
2019-03-31
|
-41.57
|
|
2018-03-31
|
-72.68
|
|
2016-03-31
|
-21.57
|
|
2015-03-31
|
-6.54
|
|
2014-03-31
|
-63.92
|
|
2013-03-31
|
-35.06
|
|
2012-03-31
|
-49.49
|
|
2011-03-31
|
-8.02
|